• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    18.59 Down 0.24(1.27%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:18.83
    Open:18.89
    Bid:0.00 x 100
    Ask:N/A
    1y Target Est:27.17
    Beta:0.82
    Earnings Date:Jul 27 - Jul 31 (Est.)
    Day's Range:18.51 - 19.08
    52wk Range:17.73 - 36.68
    Volume:345,824
    Avg Vol (3m):587,536
    Market Cap:531.15M
    P/E (ttm):N/A
    EPS (ttm):-1.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 1.27%531.15M
    AZNUp 1.19%82.68B
    MRKUp 0.12%162.93B
    PFEDown 0.95%205.48B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.82
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.77
    Quarterly EPS Est (Jun-15) :-0.36
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):-2.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback